**Purpose:** As part of the outbreak control, the capacity of laboratories to respond rapidly and properly to an emergency was significant on MERS outbreak in Korea, 2015. We investigated the effectiveness of expanded diagnostic laboratories for molecular diagnosis of MERS-CoV and evaluated the status of diagnostic system for future disease outbreak in South Korea.

**Methods & Materials:** Molecular diagnosis for MERS-CoV initially has performed by the Korea National Institute of health using in-house and customized research-use-only(RUO) version of multiplex realtime RT-PCR targeted upE and ORF1a gene based on WHO guideline. A total of 17 Provincial level laboratories(PHERI) were only prepared for screening test using RUO realtime RT-PCR kit targeted upE, and evaluated through a national EQA program.

However, with the increase of demand for test, MERS-CoV laboratory network has been continuously expanded. PHERI and 5 private diagnostic centers started to test for screening and confirmation since June 7th, and 40 designated hospitals were only performed screening test by the reason of no reporting using 4 kinds of RUO commercial kits. To assess the quality of molecular diagnostics, external quality assessment (EQA) allowing the laboratories was set out using blinded panel test and confirmatory test. In this study, a retrospective review of laboratory reporting data was carried out of all patients suspected of MERS-CoV during the MERS outbreak.

**Results:** KNIH reduced the test time using 1 steps of screening and confirmation, simultaneously, instead of 2 steps regarding to WHO algorithm. A total of 44,748 MERS-CoV tests had been performed, and 733 were positive. The number of confirmed cases increased gradually and peaked on the early of June, and MERS virus testing peaked in mid-to-late June(over 1000 test per a day) and waning by July. More than 76% of testing was completed within one day. Most of the specimens(80%) were sputum and lower respiratory specimen.

**Conclusion:** During the MERS outbreak in Korea, laboratory cooperation and expansion has been well initiated testing massive quantities of specimens from patients suspecting MERS-CoV infection. However, several improvements may allow to more successful cooperation for effective disease control and future research.
